Skip to main content


New CME event
Where Debate & Discussion Translate to Better Treatments
The Great Debates & Updates in Hematologic Malignancies Series is Expanding!

We are now offering four virtual and one live multi-day, debate-driven conferences focusing on the treatment of hematologic malignancies. Attendees can expect a comprehensive overview of the most significant advances in multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, as well as take-home information to immediately implement in your practice.

The unique format will include didactic presentations and lively and interactive debates, covering some of the most controversial and relevant topics in the field.  These conferences are sure to be an engaging, interactive educational opportunity for attendees allowing for the ability to network with both faculty and attendees alike. 

With five meeting dates available, the 2022 Great Debates and Updates Series allows you to choose the best date that fits your schedule. Virtual and Live options available. 

Interactive Format. Practical Implications.

The agenda features a mix of clinical updates and lively debates on provocative scientific topics impacting the field, such as multiple myeloma, acute and chronic lymphocytic and myeloid leukemia, lymphoma, and so much more.

Scientific Sessions
CME Credits
Expert Faculty
Who Should Attend?

These live educational activities are designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, acute and chronic lymphocytic leukemia, and myeloid malignancies.

Medical Oncologists
Physician Assistants
Oncology Nurses
Who Should Attend
Featured Topics

As an event best known for its unique, debate-style format, the 2022 agenda features a mix of didactic lectures and debates, examining the latest and most controversial topics across the board in the field of hematologic malignancies. 

Multiple Myeloma
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasms
Special Topics in Hematologic Malignancies
Meet the Chairs
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center
Northwestern University
Chicago, Illinois
John P. Leonard, MD
Center for Lymphoma and Myeloma
Weill Cornell Medicine
New York, New York
Joseph R. Mikhael, MD, MEd, FRCPC
Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Phoenix, Arizona

Keep Me Informed